Skip to main content
Top

Annals of Hematology

Issue 7/2007

Content (16 Articles)

Original Article

A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells

Manchao Zhang, Yan Ling, Chao-Yie Yang, Hongpeng Liu, Renxiao Wang, Xihan Wu, Ke Ding, Feng Zhu, Brian N. Griffith, Ramzi M. Mohammad, Shaomeng Wang, Dajun Yang

Original Article

Status of HFE mutation in thalassemia syndromes in north India

Sarita Agarwal, D. Tewari, V. Arya, N. Moorchung, R. Tripathi, G. Chaudhuri, M. Pradhan

Original Article

Discrimination indices as screening tests for β-thalassemic trait

George Ntaios, Anastasia Chatzinikolaou, Zoi Saouli, Fotios Girtovitis, Maria Tsapanidou, Georgia Kaiafa, Zisis Kontoninas, Androula Nikolaidou, Christos Savopoulos, Ifigenia Pidonia, Stiliani Alexiou-Daniel

Original Article

Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome

A-Reum Han, Hye Ran Lee, Byeong-Bae Park, In Gyu Hwang, Sarah Park, Sang Cheol Lee, Kihyun Kim, Ho Yeong Lim, Young H. Ko, Sun Hee Kim, Won Seog Kim

Original Article

Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature

Jaspreet S. Grewal, Lauren B. Smith, Jerome D. Winegarden III, John C. Krauss, Joseph A. Tworek, Bertram Schnitzer

Original Article

High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage

Christian Hallermann, Matthias Kaune Kjell, Markus Tiemann, Ekkehard Kunze, Frank Griesinger, Christina Mitteldorf, Hans-Peter Bertsch, Christine Neumann

Erratum

High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage

Christian Hallermann, Kjell Matthias Kaune, Markus Tiemann, Ekkehard Kunze, Frank Griesinger, Christina Mitteldorf, Hans-Peter Bertsch, Christine Neumann

Original Article

Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry

Ma. Jesús Bruscas, José Antonio Nieto, Monserrat Perez-Pinar, Luciano López-Jiménez, Carmen Fernández-Capitán, Francisca López-Chuliá, Ma. Teresa Orue-Lecue

Letter to the Editor

Familial multiple myeloma: first case reported in a Mexican family

Víctor Hugo Jiménez Zepeda, Virginia Jeanet Domínguez

Letter to the Editor

Multiple myeloma of the liver presenting as non-obstructive jaundice

Ch. Ben Taarit, H. Ajlani, F. Fareh, R. Zermani, S. Ben Jilani, W. Gharbi, H. Ben Maiz, A. Khedher

Letter to the Editor

Secondary myelodysplastic syndrome after hydroxychloroquine therapy

Alaa A. Muslimani, Timothy P. Spiro, Asif A. Chaudhry, Hamed A. Daw

Letter to the Editor

Painful sensory neuropathy associated with hereditary spherocytosis

Saša A. Živković, David Lacomis

Letter to the Editor

Imatinib-induced Stevens–Johnson syndrome: recurrence after re-challenge with a lower dose

Manoranjan Mahapatra, Pravas Mishra, Rajat Kumar

Letter to the Editor

Profuse erythema multiforme induced by chlorambucil

Atilla Ozkan, Emel Bulbul Baskan, Ridvan Ali, Fahir Ozkalemkas, Hakan Turan, Saduman Balaban Adim, Ozen Oz

Letter to the Editor

Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage

Laurent Pérard, Nathalie Costedoat-Chalumeau, Nicolas Limal, Arnaud Hot, Judith Cohen, Danièle Vauthier-Brouzes, Ania Nieszkowska, Nadia Belmatoug, Jean-Charles Piette

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.